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Determining serotype for Haemophilus influenzae (Hi) and serogroup for Neisseria meningitidis (Nm) is 
crucial for identifying potential outbreaks and determining appropriate public health responses. Several 
new commercial multiplex polymerase chain reaction (PCR) assays capable of simultaneously testing a 
single specimen for an array of pathogens that cause blood infections, meningitis, or encephalitis are 
available. These assays can rapidly identify Hi and Nm species, but most do not determine serotype or 
serogroup. Laboratories should continue to perform culture and use validated, specific real-time PCR 
assays capable of detecting and differentiating all six serotypes (a-f) of Hi and six serogroups (A, B, C, W, 
X, and Y) of Nm; otherwise, additional steps need to be taken including performing a reflex culture or at a 
minimum retaining a clinical sample for further testing. 
 
Background 
CDC is aware of recent instances in which it was not possible to determine whether cases of Nm were 
part of a cluster due to the lack of serogroup data. For these cases, multiplex PCR assays capable of 
simultaneously testing a single specimen for an array of pathogens that cause blood infections, 
meningitis, or encephalitis were used. While such assays can rapidly identify Hi and Nm species, most do 
not determine serotype or serogroup. Detecting serotype and serogroup are important for identifying 
potential outbreaks and determining appropriate public health responses. 
 
Recommendations 
Clinical, commercial, and state public health laboratories considering PCR for Hi and Nm should select 
assays capable of detecting and differentiating all Hi serotypes (serotypes a-f) and all Nm serogroups 
common in the United States (serogroups B, C, W, and Y). If a public health laboratory is not able to 
perform serotyping or serogrouping by PCR and a culture isolate is not available, the laboratory should 
send specimens to the CDC Bacterial Meningitis laboratory or one of the Association of Public Health 
Laboratories (APHL) Vaccine Preventable Diseases Reference Laboratories for serotype/serogroup 
testing (see links in the For More Information section). 
 
All laboratories with Hi and Nm PCR capacity are strongly encouraged to continue performing culture or 
to save clinical specimens for further testing and submission to state health departments and CDC. Hi 
and Nm culture isolates are valuable not only for serotyping or serogrouping but also for monitoring 
antimicrobial susceptibility and for conducting whole genome sequencing, which is necessary for strain 
comparisons during outbreak investigations and to monitor vaccine effectiveness over time. 
 
All laboratories that use assays that do not determine serotype or serogroup should perform either a 
simultaneous culture or a reflex culture if Hi or Nm is identified. At a minimum, adequate clinical sample 
for further testing at a laboratory with a PCR assay that can detect serotype or serogroup should be 
maintained.  
 
For More Information 
  
• Best Practices for Use of PCR for Diagnosing Haemophilus influenzae and Neisseria meningitidis 
and Importance of Identifying Serotype/Serogroup 
(http://www.cdc.gov/meningococcal/laboratory/pcr-guidance-mening-hflu.html)  
• CDC Bacterial Meningitis Laboratory (http://www.cdc.gov/meningococcal/laboratory.html)  
• Association of Public Health Laboratories (APHL) Vaccine Preventable Diseases Reference 
Laboratories (http://www.aphl.org/programs/infectious_disease/Pages/VPD.aspx)  
 
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 




Categories of Health Alert Network messages:  
Health Alert  Requires immediate action or attention; highest level of importance 
Health Advisory May not require immediate action; provides important information for a specific incident or situation 
Health Update  Unlikely to require immediate action; provides updated information regarding an incident or situation 
HAN Info Service Does not require immediate action; provides general public health information 
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